Tildrakizumab for Psoriasis Shows Durable Efficacy Over 5 Years ...Middle East

Medscape - News
The full 5-year results of a study of tildrakizumab for psoriasis show a high rate of sustained disease control coupled with a favorable safety profile during more than 5400 patient-years of follow-up. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Tildrakizumab for Psoriasis Shows Durable Efficacy Over 5 Years )

Apple Storegoogle play

Also on site :

Most viewed in News


Latest News